Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.2K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

5.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
5.9K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

467
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
467
Protein-protein Interfaces02:04

Protein-protein Interfaces

12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
Protein Networks02:26

Protein Networks

3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A prospective multimethod investigation of cancer-related pain integrating clinical data and machine learning: results from the RUGGI Study.

Journal of anesthesia, analgesia and critical care·2026
Same author

A personalized iodine delivery rate-based injection protocol in coronary angiography on photon-counting CT.

European radiology·2026
Same author

Comparative analysis of different treatment modalities for management of cutaneous warts: A systematic review and network meta-analysis.

Medicine·2026
Same author

The clinical and physiological profiles of kissing stents in endovascular reconstruction of aortoiliac occlusive disease.

Experimental physiology·2025
Same author

Management of Autoimmune Conditions Associated With Thymic Epithelial Tumors.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2025
Same author

Accelerometer-Derived Total Activity and Cardiometabolic Health Factors among US Adults, NHANES 2011-2014.

Medicine and science in sports and exercise·2025

Related Experiment Video

Updated: May 17, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.3K

Identifying novel drug targets with computational precision.

Riya Dave1, Pierpaolo Giordano2, Sakshi Roy3

  • 1Dentist, Gujarat University, Ahmedabad, Gujarat, India.

Advances in Pharmacology (San Diego, Calif.)
|April 2, 2025
PubMed
Summary
This summary is machine-generated.

Computational precision drug discovery uses advanced computing to rapidly identify therapeutic targets. This revolutionizes treatment development for complex diseases, enabling personalized medicine.

Keywords:
BioinformaticsComputational drug discoveryDrug target identificationEthical considerationsMachine learningPrecision medicine

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

4.7K

Related Experiment Videos

Last Updated: May 17, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.3K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

4.7K

Area of Science:

  • Computational drug discovery
  • Bioinformatics
  • Genomics
  • Proteomics
  • Systems Biology
  • Network Pharmacology

Background:

  • Traditional drug discovery methods face challenges in analyzing complex biological data.
  • Increasing need for faster, more precise identification of therapeutic targets.
  • Advancements in computing power and algorithms enable sophisticated data analysis.

Purpose of the Study:

  • To highlight the transformative role of computational precision in drug discovery.
  • To showcase how integrated computational and experimental approaches accelerate therapeutic development.
  • To emphasize the shift towards personalized medicine through advanced analytics.

Main Methods:

  • Utilized next-generation sequencing for genetic characterization.
  • Employed proteomics to study protein expression and disease mechanisms.
  • Applied in-silico methods: molecular docking, virtual screening, pharmacophore modeling.
  • Incorporated structure-based drug design and molecular dynamics simulations.
  • Leveraged ligand-based methods for predicting compound activities.
  • Integrated Artificial Intelligence (AI) and machine learning for data optimization.
  • Adopted systems biology and network pharmacology for holistic biological network analysis.

Main Results:

  • Accelerated identification of early drug candidates through in-silico screening.
  • Enhanced precision in drug design by elucidating target structures and molecular behaviors.
  • Improved predictive accuracy in identifying novel therapeutic targets via AI and machine learning.
  • Identification of critical nodes in biological networks overlooked by traditional methods.
  • Synergistic integration of computational tools with experimental techniques.

Conclusions:

  • Computational precision drug discovery represents a paradigm shift in modern medicine.
  • This multi-dimensional approach delivers safer, more effective, and personalized treatments.
  • Integration of bioinformatics, genomics, and proteomics transforms therapeutic intervention development.
  • Paves the way for an era of personalized and efficient healthcare.